Delcath Systems (DCTH) Tops Q4 EPS by 6c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall St set to open higher as tech rebounds, Micron earnings eyed
- Brent hits lowest since before start of Iran war on expectations of smoother oil flows via Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Stay long AI-capex winners into the peak, Stifel says despite bubble fears
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Canaccord Genuity Reiterates Buy Rating on Delcath Systems (DCTH)
March 27, 2024 8:09 AM EDTCanaccord Genuity analyst Bill Maughan reiterated a Buy rating and $21.00 price target on Delcath Systems (NASDAQ: DCTH).
The analyst commented, "Delcath reported 4Q23 results this morning and gave an update on the early launch of Hepzato, which came available in January for the treatment of metastatic uveal melanoma... More
